Crestline Management, LP
- SEC CIK
- 0001536054
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 3
- 0 vs. Q2 2025
- Portfolio value
- $58.1M
- −$4.47M (−7.2%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNLIDenali Therapeutics Inc. | COM | 3,410,732 | $49.5M | 85.3% | −450,000−11.7% | Reduced | History |
| SANASana Biotechnology, Inc. | COM | 1,820,937 | $6.46M | 11.1% | −600,000−24.8% | Reduced | History |
| EGHT8X8 Inc | COM | 990,580 | $2.10M | 3.6% | 00.0% | Unchanged | History |